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Background: Although the problem of substance use among drivers is not limited to cer-
tain parts of the world, most epidemiological reports on this topic have been published
from industrial world.
Aim: To investigate pattern of drug use among Iranian drivers who were involved in fatal
road accidents.
Methods:This study enrolled 51 Iranian adults who were involved in fatal vehicle accidents
and were imprisoned thereafter. Data came from a national survey of drug abuse that was
done among Iranian prisoners. The survey collected data at the entry to seven prisons in
different regions of the country during a 4-month period in 2008. Self-reported lifetime,
last year, and last month drug use was measured. Commercial substance screening tests
were applied to detect recent substance use (opioids, cannabinoids, methamphetamines,
and benzodiazepines).
Results:The commercial substance screening test showed three distinct patterns of recent
illicit drug use: opioids (37.3%), cannabinoids (2.0%), opioids and cannabinoids (13.7%).
29.4%were also positive for benzodiazepines.The substance use screening test detected
23.5% of participants who had used drugs but did not disclose any substance use.
Conclusion: Opioids are the most common illicit drugs being used by Iranian drivers who
are involved in fatal car accidents.The high rate of substance use prior to fatal car accidents
in Iran advocates for the need for drug use control policies and programs as major strate-
gies for injury prevention in Iran. There is also a need for substance screening among all
drivers involved in fatal car accidents in Iran, as more than 20% of users may not disclose
substance use.
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INTRODUCTION
Driving under the influence of drugs happens for several reasons.
Recreational drug use may be prevalent among people who drive
(1). Drugged driving happens if the driver is a drug user (2, 3).
Drugged driving may also happen among professional drivers who
drive long distances (4). Drivers who drive under the influence of
drugs pose serious risk to others on the road (4, 5).
Although various drugs have different effects, most substances
affect driving tasks, even in low dosages (6). An increased risk of
crash may exist even in the absence of outward signs of impair-
ment in the driver (4, 6). Drug use also increases the probability
of poor outcomes following car accidents (7). It has been shown
that risk of death following traffic accidents increases when it is
secondary to substance use (7–9).
Prevention of drugged driving is an essential strategy for
prevention of mortalities and morbidities due to unintentional
injuries. Authorities, however, cannot design evidence-based poli-
cies and programs such as continued drug use education and
screening programs if they do not have access to epidemiologi-
cal information. Such information is essential for the design and
implementation of policies that should be enforced to reduce
traffic accidents attributed to drugs (4).
As the epidemiological pattern of substance use varies
from one geographic location to another, knowledge of local
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epidemiological patterns of drugged driving is necessary for the
improvement of road safety. Screening tests for substances in
suspected cases are designed based on the epidemiological infor-
mation about the type of drugs that are commonly used by drivers
who are at high risk of accidents (10). For instance, in settings
where opioids are not commonly used, suspected individuals for
drugged driving undergo drug tests that do not cover opioids (1).
Besides the enormous economic burden of drugged driving and
the fact that surveys on driving under the influence of substances
have important implications for prevention (5), limited epidemi-
ological knowledge exists on this problem in developing countries
(1). Almost all published epidemiological knowledge in this field
originates from North America, Europe, and Australia (2).
Different populations are being enrolled to the epidemiologi-
cal studies on drugged driving (8, 9, 11–17). This includes general
populations, drivers, professional drivers, and drivers who become
involved in crashes (18, 19). One of the populations that is being
studied in epidemiological surveys is drivers who are arrested or
imprisoned following a fatal crash (20).
There is very limited information regarding drugged driving in
Iran. Of the few studies that have provided epidemiological infor-
mation on drugged driving (21–25), none have sampled drivers
involved in fatal road accidents.
The main purpose of the current descriptive study was to inves-
tigate the problem of drugged driving in fatal car accidents in Iran.
We also measured possible discrepancies between self-reported
data and screening results for commonly used substances.
MATERIALS AND METHODS
DESIGN AND SETTING
This national cross-sectional study was carried out by the Health
and Treatment Bureau of the Iran Prisons Organization, Tehran,
Iran. Data collection was conducted from September to December
2008.
An ethics committee approved our study protocol. Informed
consent was received from all participants. Our participants
were reassured that data would be kept confidential. All data
were registered anonymously. No incentive was given to the
participants.
PARTICIPANTS AND SAMPLING
This study included 51 participants who were imprisoned because
of motor vehicle accidents resulting in death. Participants were
selected from 2,200 prisoners who participated in a national
survey conducted in seven prisons in different regions of the
country. Prisons were located at the following provinces: Tehran,
Azarbayjan-e Sharghi, Golestan, Sistan and Balouchestan, Yazd,
and Kermanshah. The study used a table of random numbers as
the simple random strategy to include new prisoners.
MEASURES
At the time of entry to prison, participants underwent a structured
interview using a checklist. Interviews were conducted in private
settings. All interviewers were men with master’s degrees in clinical
psychology (the same gender as the participant).
Self-reported data on drug use during lifetime, last year,
and previous month, were asked for the following drugs:
cannabis, opium, opium derivates, powder heroin, compact
heroin, Methamphetamine, cocaine, Lysergic Acid Diethylamide
(LSD), and other drugs. Data were also collected on the mode of
drug use, including: smoking, swallowing, sniffing, injecting, and
inhaling.
DRUG SCREENING
Two milliliters of blood were drawn from each participant using
vacutainer tubes. The blood was contained in a preservative and
was screened for drugs using enzyme-linked immunosorbent assay
and gas chromatography–mass spectrometry analysis. Commer-
cial screening tests were used for marijuana, meth, and opioids.
These tests detect the presence of delta-9-tetrahydrocannabinol
(THC), the active ingredient in marijuana, and of cannabis and
methamphetamine (12, 26).
DATA ANALYSIS
We used SPSS for data analysis. Due to the low sample size, this
study only provided descriptive statistics. We reported frequency
tables for categorical variables. Means and standard deviations
(SD) were reported for continuous variables.
RESULTS
DESCRIPTIVE STATISTICS
All participants were men, and most were living in urban areas.
Most participants were employed, married, and had not completed
high school. Most participants did not have a history of previous
imprisonment (Table 1).
Table 1 | Socio-demographic data among individuals who were
imprisoned for fatal car accidents (n=51).
n %
LIVING PLACE
Urban 32 62.7
Rural 19 37.3
EDUCATIONAL LEVEL
Illiterate 7 13.7
Read/write 2 3.9
Primary school 13 25.5
Guidance school 16 31.4
High school 3 5.9
Diploma 6 11.8
University 4 7.8
MARITAL STATUS
Single 16 31.4
Married 34 66.7
Divorced 1 2.0
EMPLOYMENT
Employed 47 92.2
Jobless 4 7.8
PREVIOUS IMPRISONMENT
No 26 51.0
Once 18 35.3
Two times or more 7 13.7
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Participants’ ages ranged from 21 to 56 years, with a mean (SD)
of 32.4± 7.9 years. Monthly income ranged from 0 to $1,200,
with a mean (SD) of $290± 211. Family size ranged from 1 to
14 persons with a mean (SD) of 4± 2 persons.
SELF-REPORTED RESULTS
Based on self-reported data, the most frequently used drug during
the last 30 days was opium (25%) followed by heroin or opium
derivate (20%). Eight percent reported cannabis use. Although
4% reported alcohol use in their life time, none of the par-
ticipants reported alcohol use over the past 30 days. The most
common mode of drug use was smoking (81% of cases), followed
by swallowing (17.5% of cases) (Table 2).
DRUG SCREENING
Drug tests were positive for opioids, cannabis, and both in 37.3,
2.0, and 13.7%, respectively. Of all participants, 29.4% tested pos-
itive for benzodiazepines. The drug screening test detected that
23.5% of the total sample were drug users who had not reported
drug use (Table 3).
Of the participants who had not reported drug use, 24%
(n= 12) tested positive for illicit drugs. The false negative report of
Table 2 | Self-reported history of drug use among Iranian adults
imprisoned for car accident offenses (n=51).
Lifetime Last year Last month
n % n % n %
CANNABIS
No 41 80 45 88 47 92
Yes 10 20 6 12 4 8
OPIUM
No 30 59 36 71 38 75
Yes 21 41 15 29 13 25
METH
No 49 96 49 96 51 100
Yes 2 4 2 4 0 0
ECSTASY
No 50 98 50 98 51 100
Yes 1 2 1 2 0 0
HEROIN
No 35 69 38 75 41 80
Yes 16 31 13 25 10 20
OPIUM DERIVATE
No 14 27 38 75 41 80
Yes 37 73 13 25 10 20
OPIOIDS
No 24 47 27 53 30 59
Yes 27 53 24 47 21 41
ANY DRUG
No 24 47 27 53 30 59
Yes 27 53 24 47 21 41
ALCOHOL
No 49 96 51 100 51 100
Yes 2 4 0 0 0 0
no drug use was seen for cannabis (10–12%),and opioids (6–14%),
but not for Meth (0%) (Table 4).
DISCUSSION
Based on our study, 60% of Iranian drivers who are involved in
fatal car accidents use drugs. In the absence of drug screenings,
1/3 of the total number of drug users will be missed. As a result,
investigation of drugged driving among Iranians who are involved
in fatal car accidents should not merely rely on self-reported data.
The most commonly used drugs among drivers involved in fatal
crashes are opioids, followed by cannabis.
The high rate of drug use among Iranians who are impris-
oned for fatal crashes can be explained by the known association
between driving under the influence of drugs and the incidence
and intensity of car accidents (9). Drugs impair mental func-
tion and reduce attention and concentration on driving tasks. In
general, use of substances during driving may impair coordina-
tion, increase reaction time, and alter judgment of distance and
speed. Drug use results in distortion of time, place, and space.
Other effects of drug use are poor vision and muscle weakness. All
Table 3 | Drug test results among Iranian adults imprisoned for car
accident offenses (n=51).
n %
OPIOIDS
Positive 26 51
Negative 25 49
METH
Positive 0 0
Negative 51 100
CANNABIS
Positive 8 16
Negative 43 84
Table 4 | Frequency of false negative of drug use among Iranian adults
imprisoned for car accident offenses (n=51).
n %
OPIOIDS
Life time 3 6
Last year 5 10
Last month 7 14
CANNABIS
Last month 6 12
Last year 5 10
Life time 5 10
METH
Life time 0 0
Last year 0 0
Last month 0 0
ANY DRUG
Last month 12 24
Last year 10 20
Lifetime 12 24
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these consequences of drug use increase risk and severity of traffic
accidents (4, 6).
We could not find any published information about the epi-
demiology of drug use among drivers who were involved in fatal
crashes in Iran. Most of the available knowledge in Iran is about
the pattern of illicit drug use among drivers. In one study, 0.42%
of applicants for driving licenses in Iran had positive opioid test
results (21). In another study in Kerman, Iran, between 14.6 and
26.5% of drivers were opium addicts (23, 24). Kerman has one of
the highest prevalence of opium use in Iran (27, 28).
A major part of the literature has enrolled drivers who were
suspected of driving under the influence of drugs (1, 29–32).
There are also few international studies on individuals involved
in car accidents (12, 20). In Australia, cannabis (46.7%) was the
most commonly found drug in injured drivers involved in motor
vehicle collisions. The second most prevalent substance was ben-
zodiazepines (15.6%), followed by opiates (11%), amphetamines
(4.1%) methadone (3%), and cocaine (1.4%) (33). In Australia,
2.7% of individuals involved in car accidents reported their use
of cannabis before the crash (33). In Hong Kong, 10% of samples
tested positive for drugs. (34).
Of the drivers killed as a result of road accidents, 48% tested
positive for alcohol or drugs. From those drivers who tested pos-
itive, 27% were positive for alcohol only; 19% for cannabis only;
28% for alcohol and cannabis (but no other drug); and 25% for
a combination of drugs, including the combination of alcohol
and/or cannabis. Of all deceased drivers who were positive for a
combination of drugs (other than alcohol or cannabis), 23% were
positive for opioids; 31% were positive for benzodiazepines; and
42% were positive for methamphetamines (35).
In contrast to our study, in many industrial countries, mari-
juana and alcohol are the most prevalent substances found among
impaired drivers who are involved in fatal or non-fatal vehicle
crashes. Other illegal drugs such as cocaine, opiates, and amphet-
amines may have lower prevalence in industrial countries (3). In
Iran, opioids are the most commonly found drug among these
individuals.
The pattern of drug use in subgroups of a community is affected
by the epidemiology of drug use in the general population. We
believe that this is not an exception for the case of driving under
the influence of drugs (36–41). In most western countries, mari-
juana and alcohol are the most prevalent drugs used by the general
population (42). In Iran, the pattern of risk associated with drug
use is different from western countries (43–49).
The most commonly used drugs in the general population of
Iran are opioids (50). In Iran, three of four illicit drug users use
opioids (51). In Iran, opium may be used for self-medication (52).
Iran has a higher rate of opium use in comparison with other
countries (53). Iran accounts for about 85% of worldwide seizures
of opium and more than 30% of worldwide seizures of heroin
and morphine (54). Traditionally, opioids have a long history for
recreational and medical use in Iran. Geographic location of Iran
has posed Iran to such risk, as Iran is on the main opium trade
route from Afghanistan to Europe (55).
Regarding the common modes of drug use, smoking, and eating
were the most common in our sample. This was expected, as smok-
ing is the most frequent mode of opioid use by the Iranian general
population (50). The same finding has been reported among pro-
fessional drivers. Based on a recent national study, opioids (46.8%)
and heroin (27.6%) were the two most common drugs used by
Iranian professional drivers (56).
Based on our study, only 4% of individuals involved in fatal
vehicle accidents report alcohol use. This rate was <1% among
professional drivers who used drugs in Iran (56). Based on some,
but not all reports, alcohol is not a commonly used substance in
Iran (57). This might be partially due to the fact that alcohol is
banned in the country. Over 98% of Iranians are Muslim, and
Islamic instructions ban its use (58–60). There are also other parts
of the world where alcohol is not a common substance used by
drivers (5, 35).
Our findings may have important public health implications
for reducing unintentional injury in Iran. Iran is a developing
country with a high incidence of fatal road accidents compared to
other societies (22, 61, 62). The rate of deaths due to road traf-
fic accidents in Iran is also higher than the global average (22).
Such high fatalities have been partly attributed to the high rate of
drugged driving in this country (23).
The current study advocates for the design and implementa-
tion of road side drug screening. Such drug testing can be routinely
implemented at police stations. Random screenings may be imple-
mented. There is also a need for a revision in current policies
regarding charges associated with drugged driving. More restric-
tive regulations may contribute to the prohibition of driving under
the influence of drugs and may promote traffic safety in Iran.
Post-crash drug screening of drivers is not routine in several
countries around the world. In several industrial countries, drug
analysis is not conducted unless there is a request by a police offi-
cer. We believe that universal drug screening of drivers who are
involved in fatal motor vehicle collisions is needed in Iran. We
also believe that tests should cover opioids and cannabis use, while
alcohol may not be a major problem.
Countries that do not implement drug screening tests may have
high rates of drugged driving (33). An important component of
road safety efforts is anti-substance driving policies. Such policies
may decrease the societal burden attributed to drug use by motor
vehicle drivers (63, 64). Drugs covered by the screening tests should
be tailored to each country. The findings of this study on the pat-
tern of drug use among Iranian drivers who have been involved in
fatal accidents may help Iranian policy makers with designing and
implementing such screening tests. Our study findings advocate
for the universal screening of all fatal accidents, or at least selected
screening of suspected drivers.
The disturbingly high rate of drug use among individuals who
are involved in fatal car accidents in Iran is an alarm and requires
further initiatives to prevent fatalities due to drug related motor
vehicle accidents. Based on our results, drug impaired driving
laws in Iran should be revised in several ways. New policies will
empower police force to detect drivers that are impaired by drugs.
Our findings highlight the need for various preventive mea-
sures to enhance road safety in Iran. Health education programs
of drivers should include persuasive communication messages that
minimize the rate of substance use among drivers. For teen dri-
vers, education by parents is key and may be effective (65, 66).
These interventional programs should emphasize common licit
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and illicit substances that influence driving performance and result
in accidents and fatalities in each country (67). Intervention stud-
ies may test the efficacy of programs in changing driving behaviors
and associated attitudes and beliefs among drivers (65, 66). Edu-
cation material needs to be included in the education system and
practiced from the school age. Education campaigns should also
use public and mass media for education of the public. Strict reg-
ulations for issuing and renewing driver’s licenses may also lower
rates of drugged driving and prevent fatalities associated with road
traffic accidents (56).
The current study had several limitations. The data were not
updated, as data were collected in 2008. The sample size was
also small. The results may not be representative of all dri-
vers or fatal road accidents in Iran. Data were not available on
professional drivers who drive for a living or they were merely
vehicle operators. Also, we did not know the location of the
accidents (metropolitan areas or high-speed inter-city highways).
These limitations were present because the main study was not
designed specifically for the investigation of the pattern of drug
use among drivers who were involved in fatal accidents, but had
instead aimed to investigate drug use among Iranian prisoners.
The current study used only a subsample of the participants of
the main study in whom reason for imprisonment was a fatal
road accident. The study, however, had a few strengths, as well.
This was one of very few studies on the pattern of drug use
in fatal accidents in Iran. The study did not solely rely on self-
reported data, as it also implemented screening tests. Further
studies with large and random sample sizes are needed. Pub-
lished guidelines should be consulted for future drugged driving
research (12).
CONCLUSION
In Iran, relying on self-reported data will result in under-
estimation of contribution of drugged driving to the fatal road
accidents in Iran. Thus, drug screening tests should be imple-
mented for all, or at least suspected cases, of drugged driving. Opi-
oids and cannabis should be included in drug screening protocols
of Iranian drivers.
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